Search
-
Predicting Opportunity in Emerging Therapies
We offer guidance for navigating these complex markets, emphasizing the need for robust primary market research, expert consultation, and a deep understanding of stakeholder perceptions.
-
ESG Strategies & Brand Building with New Canadians
Revisit our on demand webinar for insights from the Ipsos New Canadians Research Community, a 200+ member online community of new-to-Canada residents.
-
Oncology: the power of holistic insights
Understanding why real-world treatment in oncology can be sub-optimal – and what can be done about it.
-
Speeding Between the Gates
Read more about our agile stage-gate framework where multiple stakeholders and teams can launch an innovation without losing the initial intended promise, originality and ability to disrupt.
-
Conquering Complexity: The ongoing revolution in oncology biomarker testing
The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalized medicine now well-entrenched in the treatment paradigm.
-
Start with the end in mind: A three-step segmentation remedy
Segmentation has often faced criticism for lacking effectiveness, but by starting with the end in mind organizations can ensure success.
-
Up Close and Personal: Humanizing Omnichannel
Ipsos has identified six drivers of customer experience, only three of which relate to convenience. The other three are enjoyment, belonging, and status.
-
Harnessing the Power of Data
We share perspectives exploring how organizations are evolving to harness the power of data and technology for better insights.
-
Social Intelligence in Pharmaceuticals
In our latest white paper series, we explore the topic of digital readiness while breaking down the online commentary related to FDA’s approval of ADUHELM (aducanumab).
-
Telemedicine: Real Experiences; Real Insights
We interviewed HCPs, Patients, and Payers to understand how these key stakeholders currently experience telemedicine and how they are likely to use it in the future.